Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

BK7508 Pharmaceutical Companies

Not Yet Opened 07-16 16:00:00 AEST

495.65

+3.74

+0.76%

High498.50	Low491.45	Vol41.65M
Open494.43	D1 Closing491.90	Amplitude1.43%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O116.92M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":495.64648,"timestamp":1784181599577,"preClose":491.90292,"halted":0,"volume":41651345,"delay":0,"changeRate":0.00761,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":3.743561,"latestTime":"07-16 16:00:00 AEST","open":494.43005,"high":498.50168,"low":491.4465,"amount":116920934.043,"amplitude":0.014343,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1784246400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1784160000000,1784181600000]],"turnoverRate":0.001664,"increases":10,"decrements":14,"flats":18,"marketCap":69308084534.75,"floatMarketCap":66142922719.5},"requestUrl":"/m/hq/s/BK7508/wiki","defaultTab":"wiki","newsList":[{"id":"2651344388","title":"Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344388?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:00","pubTimestamp":1784196001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA1KDQZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651356415","title":"Founder Led Stocks For Investors Watching Australian Small Caps Closely","url":"https://stock-news.laohu8.com/highlight/detail?id=2651356415","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651356415?lang=en_us&edition=fundamental","pubTime":"2026-07-16 12:44","pubTimestamp":1784177081,"startTime":"0","endTime":"0","summary":"Founder led companies can look especially interesting when inflation, energy costs, and interest rate expectations are pulling markets in different directions. While global data points from US inflation readings to uneven growth in China and mixed signals in Europe keep broad indices on edge, founders often have a large personal stake in long term outcomes. The Founder-Led Companies screener focuses on leaders who built their business and still sit in the driver’s seat. In this article, you...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-stocks-for-investors-watching-australian-small-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XKO.AU","IMLC.AU","MQG.AU","DACE.AU","IISV.AU","VGFPF","GIVE.AU","ISBC","ZYAU.AU","XJO.AU","VAP.AU","IIGF.AU","BEAR.AU","BK7508","E200.AU","BK7501","MSB.AU","GEAR.AU","BBOZ.AU","BK7046","BK7067","QFN.AU","XAO.AU","BK7043","BK7042","BK7070","BK7511","EIGA.AU","FEBU","STW.AU","FLT.AU","BK4211","VAS.AU","VOTE","GXDW","OZF.AU","IOZ.AU","DECU","QRE.AU","MAQ.AU","SLF.AU","OZR.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651492718","title":"Immuron Logs FY Global Sales A$7.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651492718","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651492718?lang=en_us&edition=fundamental","pubTime":"2026-07-16 09:26","pubTimestamp":1784165163,"startTime":"0","endTime":"0","summary":"BRIEF-Immuron Logs FY Global Sales A$7.7 MillionJuly 16 (Reuters)-Immuron LtdIMC.AX:FY26 GLOBAL SALES A$7.7 MILLION, UP 6% ON PRIOR COMPARATIVE PERIODFurther company coverage:IMC.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43H1K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMC.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651494298","title":"Immuron - FY26 Global Sales A$7.7 Mln, up 6% on Prior Comparative Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2651494298","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651494298?lang=en_us&edition=fundamental","pubTime":"2026-07-16 08:22","pubTimestamp":1784161372,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43H1K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497376","title":"CSL Stock And 2 Income Shares For Steadier Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497376","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651497376?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:33","pubTimestamp":1784154832,"startTime":"0","endTime":"0","summary":"With inflation readings moving in different directions across regions and interest rate expectations shifting month by month, many investors are looking for ways to let income, not headlines, do more of the work. That is where the Dividend Powerhouses screener comes in, focusing on stocks offering more than a 5% yield that is covered by current earnings, growing over time and historically steady. This article highlights 3 dividend stocks from that group that stand out on those criteria and...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-income-shares-for-steadier-dividends","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/csl-stock-and-2-income-shares-for-steadier-dividends","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["UYM","LU1169590202.USD","LU0728928796.USD","BK4086","EVN.AU","BK7104","BK7508","BK7034","BK4535","BK7067","CSL.AU","BK7511","QBE.AU","BK7501","PICK","BK7506","SGXZ23171101.USD","CSL","SG9999004303.SGD","LU1169589451.USD","XME"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651993584","title":"Top ASX Dividend Stocks For July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651993584","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651993584?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:09","pubTimestamp":1784142556,"startTime":"0","endTime":"0","summary":"As Australian shares experience a modest rise, buoyed by strong U.S. bank earnings and easing consumer prices, investors are increasingly optimistic about the Federal Reserve's potential pause on rate hikes. In this climate of cautious optimism and geopolitical tensions, dividend stocks stand out as a reliable choice for those seeking steady income amidst market fluctuations.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-july-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-july-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STW.AU","XJO.AU","XAO.AU","BK7118","BK7016","GIVE.AU","EIGA.AU","PPC.AU","GEAR.AU","HDV","IOZ.AU","BK7501","WAT.AU","ZYAU.AU","IMLC.AU","VIG","OCL.AU","BK7135","BK7078","BK7508","OZF.AU","SDF.AU","EQT.AU","42R.SI","E200.AU","KSL.AU","BEAR.AU","JIN.AU","FID.AU","CLX.AU","BK7145","IIGF.AU","BK7058","VAP.AU","IISV.AU","QRE.AU","XKO.AU","MFF.AU","CSL.AU","DACE.AU","BBOZ.AU","BK7101","VAS.AU","SLF.AU","BK7062","BK6000","OZR.AU","BK7067","BK6505","QFN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651994644","title":"ASX Growth Companies With High Insider Ownership In July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651994644","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651994644?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:08","pubTimestamp":1784142482,"startTime":"0","endTime":"0","summary":"As the Australian market shows signs of strength with a 0.55% advance, buoyed by positive U.S. economic signals and tempered geopolitical tensions, investors are keenly observing growth opportunities on the ASX. In such an environment, companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for future success.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-vmm/viridis-mining-and-minerals-shares/news/asx-growth-companies-with-high-insider-ownership-in-july-202-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-vmm/viridis-mining-and-minerals-shares/news/asx-growth-companies-with-high-insider-ownership-in-july-202-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SPL.AU","AEM.AU","BK7016","LIN.AU","BK7110","VMM.AU","PDI.AU","BK7084","BK7508","BK7501","BK7062","FRS.AU","TOR.AU","AV1.AU","AR1.AU","AWJ.AU","BK7104","PNI.AU","BK7023","BK7095","BK7096","SKS.AU","BK7017","CDA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651586499","title":"ASX Stocks Estimated To Be Trading Below Intrinsic Value In July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651586499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651586499?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:04","pubTimestamp":1784142271,"startTime":"0","endTime":"0","summary":"The Australian stock market is experiencing a modest uptick, buoyed by positive developments in U.S. bank earnings and easing consumer prices, with the ASX poised for a 50-point advance. In this environment of cautious optimism and geopolitical tensions, identifying stocks trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst fluctuating economic conditions.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3041000-choice1-main-header/1585186744280"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/capital-goods/asx-syl/symal-group-shares/news/asx-stocks-estimated-to-be-trading-below-intrinsic-value-in-4","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/capital-goods/asx-syl/symal-group-shares/news/asx-stocks-estimated-to-be-trading-below-intrinsic-value-in-4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7062","PNV.AU","BBT.AU","BK7078","BK7153","MFG.AU","BK7049","BK7126","BK7015","XRO.AU","SPHQ","BK7002","BK7508","SLC.AU","BK4588","KGN.AU","FDV.AU","SXE.AU","BK4585","BK7503","NGI.AU","NWH.AU","BK7055","SYL.AU","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651650194","title":"How Investors Are Reacting To Neuren Pharmaceuticals (ASX:NEU) Larger-Than-Expected Phelan-McDermid Syndrome Population Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2651650194","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651650194?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:26","pubTimestamp":1784111213,"startTime":"0","endTime":"0","summary":"In June 2026, Mount Sinai’s Seaver Autism Center published research in Autism Research estimating Phelan-McDermid syndrome affects about 1 in 7,300 people, a much higher prevalence than earlier thought, in a study supported by CureSHANK and Neuren Pharmaceuticals. \nThis substantially larger patient population estimate highlights a potentially wider addressable market for ongoing precision medicine trials and future therapies targeting Phelan-McDermid syndrome. \nWe’ll now examine how this...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/how-investors-are-reacting-to-neuren-pharmaceuticals-asxneu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-neu/neuren-pharmaceuticals-shares/news/how-investors-are-reacting-to-neuren-pharmaceuticals-asxneu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BK4109","BK4211","NEU","NEU.AU","BK7096","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651395774","title":"Orthocell June Quarter Highlights Strong Revenue Growth, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2651395774","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651395774?lang=en_us&edition=fundamental","pubTime":"2026-07-15 12:27","pubTimestamp":1784089629,"startTime":"0","endTime":"0","summary":"Orthocell (ASX:OCC) delivered strong fiscal year 2026 revenue growth while continuing to expand the US commercial rollout of Remplir, with improving hospital access and surgeon adoption supporting its","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OCC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651143137","title":"How Margin Pressures, Impairments and Leadership Shifts At CSL (ASX:CSL) Have Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2651143137","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651143137?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:39","pubTimestamp":1784086784,"startTime":"0","endTime":"0","summary":"In recent weeks, CSL has remained under close investor scrutiny as it works through plasma margin pressures, cash conversion challenges, leadership changes and multi‑billion‑dollar impairments linked mainly to the CSL Vifor acquisition. \nThis combination of operational scrutiny and capital management questions is shaping how investors assess the quality and resilience of CSL’s healthcare franchise ahead of upcoming results and any decision on a potential Seqirus demerger.\nWith plasma margin...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-margin-pressures-impairments-and-leadership-shifts-at-cs","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-margin-pressures-impairments-and-leadership-shifts-at-cs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","LU0728928796.USD","ARTY","CSL.AU","CHAT","BK4086","LU1169589451.USD","LU1169590202.USD","AIPO","BK7067","BK7501","SGXZ23171101.USD","QTOC","CSL","BK7508","VTHR","SG9999004303.SGD","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651435245","title":"Starpharma Completes Manufacturing of HER2-Positive Cancer Therapy Candidate Precursor Ahead of First-in-Human Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2651435245","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651435245?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:14","pubTimestamp":1784085279,"startTime":"0","endTime":"0","summary":"Starpharma Holdings (ASX:SPL) completed the GMP manufacturing of the DEP HER2 precursor dendrimer during the June quarter, supporting the first-in-human first phase clinical study commencement in the ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","SPL.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651431534","title":"ASX Penny Stocks Spotlight Aroa Biosurgery And Two More Hidden Gems","url":"https://stock-news.laohu8.com/highlight/detail?id=2651431534","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651431534?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:05","pubTimestamp":1784081103,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest advance, buoyed by positive U.S. bank earnings and easing consumer prices, although geopolitical tensions continue to cast a shadow. In the current market landscape, where traditional investments face uncertainties, penny stocks offer an intriguing alternative with their potential for growth and value. Despite being perceived as relics of past trading days, these smaller or newer companies can still present significant opportunities when backed by...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/asx-penny-stocks-spotlight-aroa-biosurgery-and-two-more-hidd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/asx-penny-stocks-spotlight-aroa-biosurgery-and-two-more-hidd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","PIQ.AU","BK7129","BK7048","FEX.AU","ARX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651743814","title":"Starpharma Says Fully Underwritten Entitlement Offer to Raise A$32 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2651743814","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651743814?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:31","pubTimestamp":1784079090,"startTime":"0","endTime":"0","summary":"July 15 (Reuters) - Starpharma Holdings Ltd::*FULLY UNDERWRITTEN ENTITLEMENT OFFER TO RAISE A$32 MILLION*OFFER PRICE OF A$0.57 PER SHARE*Further company coverage: SPL.AX* ((Reuters.Briefs@thomsonreute","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nRSD89rgRY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","SPL.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651015480","title":"Australia's Starpharma Slumps to 1-1/2-month Low on Discounted Fund Raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2651015480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651015480?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:17","pubTimestamp":1784078238,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising** Shares of StarpharmaSPL.AXfall as much as 13.9% to A$0.65, marking their lowest level since May 28** Stock on track f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4N43H02C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","SPL.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651051480","title":"Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2651051480","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651051480?lang=en_us&edition=fundamental","pubTime":"2026-07-15 08:32","pubTimestamp":1784075557,"startTime":"0","endTime":"0","summary":"When bond yields climb, inflation stays in focus and headlines are dominated by energy security and geopolitical risk, many investors look for leaders with real skin in the game. That is where founder led companies come in. This Founder-Led Companies screener focuses on businesses still guided by the people who built them and who remain personally invested in long term outcomes. This article highlights 3 stocks from the screener that stand out on qualitative grounds and provides a starting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/flight-centre-stock-and-2-founder-run-asx-shares-worth-a-clo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7042","BK7511","MAQ.AU","BK7043","MSB.AU","BK7046","BK7070","BK7508","FLT.AU","MQG.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651829444","title":"Starpharma Holdings - Fully Underwritten Entitlement Offer to Raise A$32 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2651829444","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651829444?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:10","pubTimestamp":1784070632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","SPL.AU","BK7501","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482941","title":"Starpharma Holdings Ltd - Offer Price of A$0.57 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482941","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482941?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:10","pubTimestamp":1784070632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G0ZQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","SPL.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651314482","title":"Dimerix Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2651314482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651314482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:43","pubTimestamp":1784068982,"startTime":"0","endTime":"0","summary":"BRIEF-Dimerix Requests Trading HaltJuly 15 (Reuters)-Dimerix LtdDXB.AX:TRADING HALT REQUESTED PENDING NON-DILUTIVE FUNDING AND ASSET ACQUISITION ANNOUNCEMENTSFurther company coverage:DXB.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7508","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482390","title":"Dimerix - Trading Halt Requested Pending Non-dilutive Funding and Asset Acquisition Announcements","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482390?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:42","pubTimestamp":1784068961,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0178},{"period":"6month","weight":0.0019},{"period":"1year","weight":0.1209},{"period":"ytd","weight":0.0261}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}